← All Arrivent Biopharma, INC filings

Arrivent Biopharma, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
AVBP
Arrivent Biopharma, INC
DEFA14A: ArriVent BioPharma Sets Date for 2025 Annual Meeting, Outlines Voting Proposals
ArriVent BioPharma announces its 2025 Annual Meeting and provides details on voting procedures and proposals.
NASDAQ
AVBP
Arrivent Biopharma, INC
DEF: ArriVent BioPharma Sets Date for 2025 Annual Stockholder Meeting, Board Recommends Director Elections and Auditor Ratification
ArriVent BioPharma announces its 2025 annual meeting of stockholders to be held virtually on June 18, 2025, with key proposals including the election of two directors and ratification of PricewaterhouseCoopers LLP as the independent auditor.